Showing results (1701-1710 of 1,926) with videos related to
Sort By:
Pageof 193
RMD Open|November 8, 2018
Antiphospholipid syndrome: state of the art on clinical practice guidelinesMarteen Limper, Carlo Alberto Scirè, Rosaria Talarico, et al.RMD Open|November 8, 2018
Ehlers-Danlos syndromes: state of the art on clinical practice guidelinesAlberto Sulli, Rosaria Talarico, Carlo Alberto Scirè, et al.RMD Open|October 19, 2016
Juvenile idiopathic arthritis in adulthood: fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damageFilipa Oliveira-Ramos, Mónica Eusébio, Fernando M Martins, et al.RMD Open|January 27, 2017
Inflammatory lung disease a potential risk factor for onset of idiopathic inflammatory myopathies: results from a pilot studySevim Barbasso Helmers, Xia Jiang, David Pettersson, et al.RMD Open|January 27, 2017
Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohortMaureen C Turina, Nataliya Yeremenko, Floris van Gaalen, et al.RMD Open|January 27, 2017
Multireader assessment as an alternative to reference assessment to improve the detection of radiographic progression in a large longitudinal cohort of rheumatoid arthritis (ESPOIR)Frederique Gandjbakhch, Benjamin Granger, Romain Freund, et al.RMD Open|January 27, 2017
Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritisD H Huynh, T A Boyd, C J Etzel, et al.RMD Open|March 20, 2019
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]Alain Meyer, Carlo Alberto Scirè, Rosaria Talarico, et al.RMD Open|April 14, 2017
Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?Nicola Goodfellow, Julien Morlet, Surjeet Singh, et al.Pageof 193